Brain research points the way to new treatments for nicotine addiction

December 27, 2017, Rockefeller University
The interpeduncular nucleus region of a mouse brain, with Amigo1 cells shown in green. Credit: Rockefeller University

As the worldwide death toll from tobacco use continues to climb—it's currently six million per year and is expected to top eight million by 2030, according to the World Health Organization—efforts to unlock the secrets of nicotine addiction take on a distinct urgency. "Nicotine is one of the most difficult drugs to quit," says Ines Ibanez-Tallon, a scientists in the lab of Nathaniel Heintz, who is James and Marilyn Simons Professor at the Rockefeller University. For sure, while 70 percent of cigarette smokers in the U.S. say they would like to quit, each year only 3 percent are able to do so successfully.

Now, in her latest paper, Ibanez-Tallon and colleagues from Rockefeller, Mount Sinai Medical School, and the National Institute of Biological Sciences, China, move us one step closer to understanding how maintains its powerful grip on the .

The research, published this week in the Proceedings of the National Academy of Science, identifies specific chemical changes deep in the brain that help drive nicotine addiction. It also describes experiments in which the scientists were able to halt these changes in mice and discover potential targets for drugs to treat tobacco dependence.

An overlooked brain nook

Nicotine is a stimulant that works by binding to receptors widely distributed throughout the brain, causing neurons to release a variety of neurotransmitters including dopamine, which triggers feelings of pleasure. In a search for the that transmit this response, Ibanez-Tallon's group investigated how nicotine affects two midbrain structures, the interpeduncular nucleus (IPN) and the medial habenula (MHb). While these brain regions are ancient in evolutionary terms and are found in all vertebrates, including humans, they have not received much attention from scientists until recently, Ibanez-Tallon says.

Working with mice, Jessica L. Ables, first author of the study, found that chronic nicotine consumption alters the functions of a particular population of neurons inside the IPN. These altered brain cells, which she dubbed Amigo1, appear to promote nicotine addiction by disrupting the communication between the habenula and the IPN.

Normally, these brain structures have a system in place to curtail nicotine addiction. The habenula responds to a given dose of nicotine by sending an aversion signal to the IPN that decreases the reward of the drug, an effect that ultimately limits the urge to consume nicotine. After chronic exposure to nicotine, however—the mice used in the study drank nicotine-laced water for six weeks—the Amigo1 cells compromise this "braking effect" by releasing two chemicals that reduce the response of the IPN to the aversion signal from the habenula. In other words, the stop-smoking message doesn't get delivered.

The result is a "pro-addiction" response to nicotine, which the mice displayed in a behavioral test designed to measure the motivational properties of the drug. In the test, called conditioned place preference, the mice chose to spend time in a chamber where they had previously received nicotine. "If you are exposed to nicotine over a long period you produce more of the signal-disrupting chemicals and this desensitizes you," says Ibanez-Tallon. "That's why smokers keep smoking."

A possible way to curb addiction

In other experiments, her group was able to confirm that these mice's response to chronic nicotine was indeed influenced by Amigo1 neurons. When the researchers silenced these neurons using a genetic engineering technique, this eliminated the "nicotine preference" of the mice, strongly suggesting that those neurons play a role in the addictive behavior.

An additional experiment that left Amigo1 alone but blocked the production of nitric oxide (NO), one of the two addiction-driving chemicals over-expressed by the neurons, gave similar results.

"What all of this tells us is that the habenula-IPN pathway is important for smoking in humans," says Ibanez-Tallon, who plans to further investigate the Amigo1 brain cells and the they trigger, with the ultimate goal of developing new drugs. "When it comes to a massive health problem like ," she adds, "any therapeutic target we can find is potentially significant."

Explore further: Study reveals new mechanism in nicotine addiction

More information: Jessica L. Ables et al. Retrograde inhibition by a specific subset of interpeduncular α5 nicotinic neurons regulates nicotine preference, Proceedings of the National Academy of Sciences (2017). DOI: 10.1073/pnas.1717506114

Related Stories

Study reveals new mechanism in nicotine addiction

December 1, 2015
Part of the reason people find smoking difficult to quit is that each time they have a cigarette, feelings of craving, irritability and anxiety melt away. This component of addiction is known as negative reward and is controlled ...

Running away from addiction: How exercise aids smoking cessation

December 20, 2017
New research in mice sheds light on the mechanism underlining exercise's protective effect against nicotine dependence and withdrawal.

Reining in nicotine use: Midbrain habenula region plays key role in nicotine dependence

May 12, 2011
A person's vulnerability to nicotine addiction appears to have a genetic basis, at least in part. A region in the midbrain called the habenula (from Latin: small reins) plays a key role in this process, as Dr. Inés Ibañez-Tallon ...

Investigators compare effects of nicotine with and without menthol on brain and behavior

November 16, 2017
A new study from UMass Medical School researchers at the Center for Comparative Neuroimaging explores the link between mentholated tobacco and nicotine addiction. They found that menthol administered with nicotine alters ...

Nicotine withdrawal traced to very specific group of brain cells

November 14, 2013
Nicotine withdrawal might take over your body, but it doesn't take over your brain. The symptoms of nicotine withdrawal are driven by a very specific group of neurons within a very specific brain region, according to a report ...

Recommended for you

Research shows it's possible to reverse damage caused by aging cells

August 15, 2018
What's the secret to aging well? University of Minnesota Medical School researchers have answered it- on a cellular level.

This matrix delivers healing stem cells to injured elderly muscles

August 15, 2018
A car accident leaves an aging patient with severe muscle injuries that won't heal. Treatment with muscle stem cells from a donor might restore damaged tissue, but doctors are unable to deliver them effectively. A new method ...

Male tobacco smokers have brain-wide reduction of CB1 receptors

August 15, 2018
Chronic, frequent tobacco smokers have a decreased number of cannabinoid CB1 receptors, the "pot receptor", when compared with non-smokers, reports a study in Biological Psychiatry.

Byproducts of 'junk DNA' implicated in cancer spread

August 14, 2018
The more scientists explore so-called "junk" DNA, the less the label seems to fit.

Doctors may be able to enlist a mysterious enzyme to stop internal bleeding

August 14, 2018
Blood platelets are like the sand bags of the body. Got a cut? Platelets pile in to clog the hole and stop the bleeding.

Using DeepMind's neural network learning system to diagnose eye diseases

August 14, 2018
Three institutions working together have applied DeepMind's neural network learning system to the task of discovering and diagnosing eye diseases. Moorfields Eye Hospital has been working with Google's DeepMind Health subsidiary ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.